John Sullivan

John Sullivan is a Product Engineering Scientist at Trinity Biotech since January 2021, focusing on the development of lateral flow diagnostic test kits for HIV and COVID-19. Prior to this role, John worked as a Process Development Scientist at APC Ltd from October 2019 to October 2020, where contributions included the development of the innovative liposomal cancer drug Vyxeos, particularly in upscaling and client data presentation for Jazz Pharmaceuticals. John's career began as an Analytical Scientist at Enfer Group from January 2019 to October 2019, conducting ELISA testing on bovine and ovine cerebral tissue per ISO 17025 standards for the Department of Agriculture. Academic credentials include an M.Sc in Immunology from Trinity College Dublin (2017-2018), a degree in Medicinal Chemistry (2013-2017) from the same institution, and a Leaving Certificate from Christian Brothers College (2007-2013).